Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes? (Q37096432)

18 August 2017

1 reference

title

Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes? (English)

1 reference

18 August 2017

Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes? (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

4 December 2022

0 references

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830524

4 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

4 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

4 December 2022

1

T. J. Lyons

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1830524

4 December 2022

language of work or name

1 reference

1 June 1991

1 reference

full work available at URL

18 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb01624.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb01624.x/fullpdf

4 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

4 December 2022

1 reference

18 August 2017

8

1 reference

18 August 2017

5

1 reference

18 August 2017

411-419

1 reference

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01624.X

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

4 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

4 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages

4 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Non-enzymatic glycosylation of human serum lipoproteins. Elevated epsilon-lysine glycosylated low density lipoprotein in diabetic patients

4 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Low density lipoprotein undergoes oxidative modification in vivo

4 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

The measurement and mechanism of lipid peroxidation in biological systems

4 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation

4 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Structural changes in oxidised low-density lipoproteins and of the effect of the anti-atherosclerotic drug probucol observed by synchrotron X-ray and neutron solution scattering

4 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Oxygen-mediated heterogeneity of apo-low-density lipoprotein

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

4 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic

4 December 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60

4 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

4 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture

4 December 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Lipoprotein oxidation and lipoprotein-induced cytotoxicity

4 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Linoleate oxidation products and cardiovascular lesions

4 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins

4 December 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

4 December 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Inhibition of antithrombin III by lipid peroxides

4 December 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Modified forms of low density lipoprotein affect platelet aggregation in vitro

4 December 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation

4 December 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Diabetes, autoimmunity, and arteriosclerosis

4 December 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

4 December 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

4 December 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

4 December 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Probucol inhibits oxidative modification of low density lipoprotein

4 December 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

An approach to free radicals

4 December 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

A simple fluorometric assay for lipoperoxide in blood plasma

4 December 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

New approaches to the pathogenesis and treatment of diabetic microangiopathy

4 December 2022

54

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

The effect of oxidation on sorbitol pathway kinetics

4 December 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Metabolic Activity of Diabetic Monocytes

4 December 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes

4 December 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Catalysis of lipid peroxidation by glucose and glycosylated collagen

4 December 2022

58

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Glucose: a role as a free radical scavenger in biological systems

4 December 2022

59

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Lipid peroxide level in plasma of diabetic patients

4 December 2022

60

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Lipid peroxide levels of serum lipoprotein fractions of diabetic patients

4 December 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women.

4 December 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Increased diene conjugates in diabetic subjects with microangiopathy

4 December 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Reduced free radical activity detected by decreased diene conjugates in insulin-dependent diabetic patients

4 December 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Lipid peroxides and atherosclerosis

4 December 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Lipid peroxidation in diabetic rat retina

4 December 2022

67

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Ascorbate is an outstanding antioxidant in human blood plasma

4 December 2022

68

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Ascorbic acid metabolism in diabetes mellitus

4 December 2022

69

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Vitamin C metabolites and microangiopathy in diabetes mellitus

4 December 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Effect of streptozotocin diabetes on tissue ascorbic acid and dehydroascorbic acid

4 December 2022

71

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Deficiency of ascorbic acid in experimental diabetes. Relationship with collagen and polyol pathway abnormalities

4 December 2022

72

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Hyperglycemia-induced Intracellular Depletion of Ascorbic Acid in Human Mononuclear Leukocytes

4 December 2022

73

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Glutathione and its redox system in diabetic polymorphonuclear leukocytes

4 December 2022

74

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Production of 12-hydroxyeicosatetraenoic acid and vitamin E status in platelets from type I human diabetic subjects

4 December 2022

75

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Free radical activity in type 2 diabetes

4 December 2022

76

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Serum antioxidant activity in diabetes mellitus

4 December 2022

77

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects

4 December 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control

4 December 2022

79

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Nonenzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive properties

4 December 2022

80

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity

4 December 2022

81

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo

4 December 2022

82

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

4 December 2022

83

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

Enhancement of platelet aggregation by low-density lipoproteins from IDDM patients

4 December 2022

84

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01624.X

4 December 2022

Identifiers

1 reference

18 August 2017

1 reference